Top Markets
Coin of the day
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Ранг среди акций #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Цена акции
$14.66
Последняя синхронизация: 2026-08-28
Рыночная капитализация
$839.37M
Изменение (1 день)
-2.67%
Изменение (1 год)
557.32%
Страна
US
Торговля Climb Bio, Inc. (CLYM)

Категория

История цены акций Climb Bio, Inc. (CLYM)
Наивысшая цена закрытия: $15.73 2026-08-01

Наименьшая цена закрытия: $7.23 2024-09-01
История цены акций Climb Bio, Inc. с 2024 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 113.43%
2025 31.56%
2024 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH